BMO Capital analyst Thanos Moschopoulos maintains Constellation Software (TSX:CSU) with a Outperform and raises the price target from C$2250 to C$2650.
Scilex Holding Company Announces Production Increase, Product Availability, And The Brand Marketed And Distributed Under Scilex Pharmaceuticals, Inc. For ELYXYB
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute
